FLRT2 and non-small cell lung carcinoma: As the stemness of cancer cells is a major cause of drug resistance (Shen, 2022), both bioinformatics analysis (Figure 3F) and IC50 value detection (Figure 3G) exhibited that FLRT2 abrogates NSCLC cells cisplatin resistance.